Clinical Trials · NCT00331851
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 584
- Start date
- May 2006
- Locations
- 116 sites, 18 countries
- Primary endpoint
- HbA1c